Cushing’s patient’s psychiatric shifts tied to rapid Isturisa dose increase
A 43-year-old woman with Cushing’s disease developed an unusual sequence of psychiatric complications after rapid increases in her oral cortisol-lowering medication Isturisa (osilodrostat), a new case report from Japan shows. The woman first experienced a sudden worsening of her depression symptoms early in treatment, likely due to a transient rise…